1. Home
  2. ROIV vs FSS Comparison

ROIV vs FSS Comparison

Compare ROIV & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • FSS
  • Stock Information
  • Founded
  • ROIV 2014
  • FSS 1901
  • Country
  • ROIV United Kingdom
  • FSS United States
  • Employees
  • ROIV N/A
  • FSS N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • FSS Auto Manufacturing
  • Sector
  • ROIV Health Care
  • FSS Consumer Discretionary
  • Exchange
  • ROIV Nasdaq
  • FSS Nasdaq
  • Market Cap
  • ROIV 8.6B
  • FSS 7.8B
  • IPO Year
  • ROIV N/A
  • FSS N/A
  • Fundamental
  • Price
  • ROIV $12.92
  • FSS $124.95
  • Analyst Decision
  • ROIV Strong Buy
  • FSS Hold
  • Analyst Count
  • ROIV 4
  • FSS 4
  • Target Price
  • ROIV $15.50
  • FSS $127.33
  • AVG Volume (30 Days)
  • ROIV 5.2M
  • FSS 407.2K
  • Earning Date
  • ROIV 08-11-2025
  • FSS 10-30-2025
  • Dividend Yield
  • ROIV N/A
  • FSS 0.45%
  • EPS Growth
  • ROIV N/A
  • FSS 9.46
  • EPS
  • ROIV N/A
  • FSS 3.59
  • Revenue
  • ROIV $23,233,000.00
  • FSS $1,974,600,000.00
  • Revenue This Year
  • ROIV N/A
  • FSS $14.48
  • Revenue Next Year
  • ROIV $281.14
  • FSS $7.51
  • P/E Ratio
  • ROIV N/A
  • FSS $34.81
  • Revenue Growth
  • ROIV N/A
  • FSS 9.09
  • 52 Week Low
  • ROIV $8.73
  • FSS $66.47
  • 52 Week High
  • ROIV $13.08
  • FSS $130.30
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 73.31
  • FSS 54.85
  • Support Level
  • ROIV $11.85
  • FSS $120.68
  • Resistance Level
  • ROIV $13.08
  • FSS $128.65
  • Average True Range (ATR)
  • ROIV 0.31
  • FSS 2.45
  • MACD
  • ROIV 0.10
  • FSS -1.01
  • Stochastic Oscillator
  • ROIV 89.61
  • FSS 50.54

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: